CordovaCann (LVRLF) Gross Profit (2018 - 2019)
CordovaCann (LVRLF) recorded quarterly Gross Profit of -$32981.3 in Q2 2019, down 2474.75% quarter-over-quarter from $1388.8 in Q1 2019, and down 163.36% on a YoY basis from $52057.0 in Q2 2018.
CordovaCann (LVRLF) Gross Profit (2018 - 2019) Analysis & Trends
CordovaCann's Gross Profit history runs 2 years deep, the most recent figure standing at -$32981.3 for Q2 2019.
- In Q2 2019, Gross Profit fell 163.36% year-over-year to -$32981.3; the TTM figure through Jun 2019 stood at -$31233.4 (down 257.48% YoY), while the FY2025 annual figure was $3.0 million, down 0.77% from the prior year.
- Gross Profit was -$32981.3 for Q2 2019 at CordovaCann, down from $1388.8 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $4160.9 in Q1 2018 to a low of -$32981.3 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CordovaCann | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -32,981.33 |
| Jun 30, 2019 | -32,981.33 |
| Mar 31, 2019 | 1,388.83 |
| Mar 31, 2019 | 1,388.83 |
| Dec 31, 2018 | 359.11 |
| Dec 31, 2018 | 359.11 |
| Jun 30, 2018 | -12,523.47 |
| Jun 30, 2018 | -12,523.47 |
| Mar 31, 2018 | 4,160.94 |
| Mar 31, 2018 | 4,160.94 |